publication venue for
- Comparing Smouldering Myeloma High-Risk and Evolving Phenotype Definitions in the Prospective, Nationwide UK Cosmos Study 2025
- Investigating the Role of the BAFF-APRIL System in Promoting Progression of Smouldering Myeloma (SMM) 2025
- Monitoring and Management of CMV and other Viral Reactivations with Bispecific Antibodies (BsAbs) for Patients with Relapsed and Refractory Multiple Myeloma (RRMM) 2025
- Patient Perspectives of Receiving Out-patient Step-up Dosing with Bispecific Antibodies (BsAb) for Relapsed Multiple Myeloma (MM) 2025
- Evolving Disease in Smouldering Myeloma (SMM) Is Accompanied by Serial Change in Immune Marrow Composition 2024
- Longitudinal Analysis of t(11;14) and t(4;14) Genomes Reveals Distinct Evolutionary Trajectories in Multiple Myeloma 2024
- Marrow Immune Features Are Most Informative of Early MRD Negative Treatment Response in Newly Diagnosed TE Patients: Insights from the UKMRA Phase 3 RADAR Study 2024
- Oral Symptom Assessment Using Patient Reported Outcomes (PRO) for Relapsed Multiple Myeloma Patients Treated with Talquetamab 2024
- Patient Perceptions When Receiving Talquetamab for Triple Class Exposed Relapsed/ Refractory Myeloma: A Thematic Analysis 2024
- Progression From Smouldering Myeloma to Myeloma Is Accompanied by an Increase in CD56bright Bone Marrow Resident NK Cells With Reduced NK Cell Cytotoxic Capacity 2024
- Study of T Cell Receptor (TCR) Dynamics in Smouldering Myeloma (SMM) Using TCR Sequence Clustering To Infer Contribution of the Immune Microenvironment to Progression to Multiple Myeloma (MM) 2024
- Characterising risk and biology of smouldering myeloma for early detection of symptomatic myeloma: data from the UK cosmos study 2023
- Comprehensive genomic characterization of response and resistance to daratumumab based quadruplet induction in newly diagnosed multiple myeloma patients 2023
- Individualized risk in newly diagnosed multiple myeloma 2023
- Whole genome sequencing reveals significant genetic admixture in multiple myeloma patients, impacting assessment of etiology 2023
- Chemotherapy signatures reveal the evolutionary history of post-melphalan myeloid neoplasm 2022
- Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma 2022
- Case Report: Two Cases of Cryptosporidiosis in Heavily Pretreated Patients With Myeloma 2021
- Circulating cell free DNA is a biomarker for GEP70 risk score and tumor burden in myeloma 2019
- Enrichment for copy number alterations and a unique pattern of gene mutations characterize multiple myeloma in elderly patients 2019
- Long-term Analysis Of Multiple Sequential Samples Reveals Patterns Of Progression In Smoldering Myeloma 2019
- Genomic Studies Have Identified Multiple Mechanisms of Genetic Changes in Waldenstrom Macroglobulinemia 2013
- Novel M-Component Based Biomarkers in Waldenstrom's Macroglobulinemia 2011